Services

  1. Apollo™ 8/18/2023

    Apollo™ is an innovative platform that empowers you with real-time access to study data, milestones, documents, and program planning tools.

  2. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  3. Drug Substance Services 7/27/2023

    Examine our drug product manufacturing capabilities and how our skilled scientists work with customers to build a chemical in a cost-effective and timely manner throughout the clinical development process.

  4. Integrated Drug Discovery 7/1/2023

    Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.

  5. AGCellerate For mAbs 6/29/2023

    AGC Biologics has released a new program designed to deliver effective IND-ready GMP material for biopharmaceutical developers. AGCellerate offers guaranteed amounts at fixed timelines and costs –accelerating projects through development and into clinical phases.

  6. Safety Assessment Services 6/20/2023

    A full range of in vivo and in vitro testing services that can be customized for your project’s needs to expedite preclinical development while maintaining a high quality standard.

  7. One Step 6/20/2023

    Make strides with a tailored, comprehensive suite of discovery and development services to rapidly progress your project and reduce time to market.

  8. PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production 3/17/2023

    PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.

  9. Process Development: Mammalian, Bacteria And Yeast Based Success 2/17/2022

    At AGC Biologics, we have developed over 200 mammalian, bacteria and yeast-based processes, giving us the insight necessary to identify and optimize process parameters that are critical for achieving a high-quality, cost-effective manufacturing process.

  10. cGMP Aseptic Manufacturing And Sterile Fill-Finish 1/28/2022

    Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.